BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 33052245)

  • 1. Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury.
    Chen G; Xu C; Gillette TG; Huang T; Huang P; Li Q; Li X; Li Q; Ning Y; Tang R; Huang C; Xiong Y; Tian X; Xu J; Xu J; Chang L; Wei C; Jin C; Hill JA; Yang Y
    Theranostics; 2020; 10(25):11754-11774. PubMed ID: 33052245
    [No Abstract]   [Full Text] [Related]  

  • 2. Promoting effect of baicalin on nitric oxide production in CMECs via activating the PI3K-AKT-eNOS pathway attenuates myocardial ischemia-reperfusion injury.
    Bai J; Wang Q; Qi J; Yu H; Wang C; Wang X; Ren Y; Yang F
    Phytomedicine; 2019 Oct; 63():153035. PubMed ID: 31377586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Proteomics Analysis of Ischemia/Reperfusion Injury-Modulated Proteins in Cardiac Microvascular Endothelial Cells and the Protective Role of Tongxinluo.
    Li Q; Cui HH; Yang YJ; Li XD; Chen GH; Tian XQ; Jin C; Dong QT; Huang PS; Xu J
    Cell Physiol Biochem; 2017; 41(4):1503-1518. PubMed ID: 28334711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway.
    Li XD; Yang YJ; Geng YJ; Jin C; Hu FH; Zhao JL; Zhang HT; Cheng YT; Qian HY; Wang LL; Zhang BJ; Wu YL
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1255-61. PubMed ID: 20693395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tongmai Yangxin pill reduces myocardial no-reflow by regulating apoptosis and activating PI3K/Akt/eNOS pathway.
    Chen R; Chen T; Wang T; Dai X; Meng K; Zhang S; Jiang D; Wang Y; Zhou K; Geng T; Xu J; Wang Y
    J Ethnopharmacol; 2020 Oct; 261():113069. PubMed ID: 32619593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of autophagy by Tongxinluo through the MEK/ERK pathway protects human cardiac microvascular endothelial cells from hypoxia/reoxygenation injury.
    Cui H; Li X; Li N; Qi K; Li Q; Jin C; Zhang Q; Jiang L; Yang Y
    J Cardiovasc Pharmacol; 2014 Aug; 64(2):180-90. PubMed ID: 24705173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
    Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
    Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.
    Riquelme JA; Westermeier F; Hall AR; Vicencio JM; Pedrozo Z; Ibacache M; Fuenzalida B; Sobrevia L; Davidson SM; Yellon DM; Sánchez G; Lavandero S
    Pharmacol Res; 2016 Jan; 103():318-27. PubMed ID: 26607864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shear stress inhibits cardiac microvascular endothelial cells apoptosis to protect against myocardial ischemia reperfusion injury via YAP/miR-206/PDCD4 signaling pathway.
    Zhang Q; Cao Y; Liu Y; Huang W; Ren J; Wang P; Song C; Fan K; Ba L; Wang L; Sun H
    Biochem Pharmacol; 2021 Apr; 186():114466. PubMed ID: 33610591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation.
    Wang B; Yang Q; Bai WW; Xing YF; Lu XT; Sun YY; Zhao YX
    PLoS One; 2014; 9(6):e98047. PubMed ID: 24887083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor regulation of endothelial nitric oxide synthase phosphorylation is involved in isoflurane cardiac preconditioning.
    Liu Y; Paterson M; Baumgardt SL; Irwin MG; Xia Z; Bosnjak ZJ; Ge ZD
    Cardiovasc Res; 2019 Jan; 115(1):168-178. PubMed ID: 29931049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1.
    Chen GH; Xu CS; Zhang J; Li Q; Cui HH; Li XD; Chang LP; Tang RJ; Xu JY; Tian XQ; Huang PS; Xu J; Jin C; Yang YJ
    Front Pharmacol; 2017; 8():775. PubMed ID: 29163161
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
    Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
    Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury.
    Qi K; Li L; Li X; Zhao J; Wang Y; You S; Hu F; Zhang H; Cheng Y; Kang S; Cui H; Duan L; Jin C; Zheng Q; Yang Y
    PLoS One; 2015; 10(3):e0119846. PubMed ID: 25781461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cardioprotection by small netrin-1-derived peptides.
    Li Q; Cai H
    Am J Physiol Cell Physiol; 2015 Jul; 309(2):C100-6. PubMed ID: 25924621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key role of endothelium in the eNOS-dependent cardioprotection with exercise training.
    Farah C; Nascimento A; Bolea G; Meyer G; Gayrard S; Lacampagne A; Cazorla O; Reboul C
    J Mol Cell Cardiol; 2017 Jan; 102():26-30. PubMed ID: 27866931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tongxinluo attenuates oxygen-glucose-serum deprivation/restoration-induced endothelial barrier breakdown via peroxisome proliferator activated receptor-α/angiopoietin-like 4 pathway in high glucose-incubated human cardiac microvascular endothelial cells.
    Qi K; Yang Y; Geng Y; Cui H; Li X; Jin C; Chen G; Tian X; Meng X
    Medicine (Baltimore); 2020 Aug; 99(34):e21821. PubMed ID: 32846824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icariin Acts as a Potential Agent for Preventing Cardiac Ischemia/Reperfusion Injury.
    Zhai M; He L; Ju X; Shao L; Li G; Zhang Y; Liu Y; Zhao H
    Cell Biochem Biophys; 2015 Jun; 72(2):589-97. PubMed ID: 25663532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
    Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 4 signaling in dysfunction of cardiac microvascular endothelial cells under hypoxia/reoxygenation.
    Zhang Z; Li W; Sun D; Zhao L; Zhang R; Wang Y; Zhou X; Wang H; Cao F
    Inflamm Res; 2011 Jan; 60(1):37-45. PubMed ID: 20652722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.